Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Atopic dermatitis pipeline.

Authors:
Michael Lause Nanette B Silverberg

Cutis 2018 09;102(3):102

Departments of Dermatology and Pediatrics, Mt Sinai St. Luke's of the Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Download full-text PDF

Source
September 2018

Publication Analysis

Top Keywords

dermatitis pipeline
4
atopic dermatitis
4
atopic
1
pipeline
1

Similar Publications

Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies.

Authors:
Deepa S Mandlik Satish K Mandlik

Immunopharmacol Immunotoxicol 2021 Feb 28:1-21. Epub 2021 Feb 28.

Sinhgad College of Pharmacy, Vadgaon, Pune, India.

Atopic dermatitis (AD) is the long-lasting chronic inflammatory skin condition associated with cutaneous hyper-reactivity and triggered by environmental factors. The attributes of AD include dry skin, pruritus, lichenification and frequent eczematous abrasions. This has a strong heritable aspect and typically occurs with asthma and allergic rhinitis. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Natural language processing for abstraction of cancer treatment toxicities: accuracy versus human experts.

Authors:
Julian C Hong Andrew T Fairchild Jarred P Tanksley Manisha Palta Jessica D Tenenbaum

JAMIA Open 2020 Dec 5;3(4):513-517. Epub 2020 Dec 5.

Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

Objectives: Expert abstraction of acute toxicities is critical in oncology research but is labor-intensive and variable. We assessed the accuracy of a natural language processing (NLP) pipeline to extract symptoms from clinical notes compared to physicians.

Materials And Methods: Two independent reviewers identified present and negated National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) v5. Read More

View Article and Full-Text PDF
December 2020
Similar Publications

Prevalence of foot lesions in Québec dairy herds from 2015 to 2018.

Authors:
Juan C Arango-Sabogal André Desrochers René Lacroix Anne-Marie Christen Simon Dufour

J Dairy Sci 2020 Dec 15;103(12):11659-11675. Epub 2020 Oct 15.

Regroupement FRQNT Op+Lait, Saint-Hyacinthe, QC, J2S 2M2, Canada; Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, J2S 2M2, Canada. Electronic address:

Our first objective was to estimate the prevalence of foot lesions by type of milking system in dairy cows examined during regular hoof-trimming sessions between 2015 and 2018 in Québec dairy herds. A secondary objective was to describe the effect of day-to-day variation, cow, and herd characteristics on the prevalence of foot lesions. Data included 52,427 observations (on a cow during a specific trimming session) performed on 28,470 cows (≥2 yr old) from 355 herds. Read More

View Article and Full-Text PDF
December 2020
Similar Publications

New treatments in atopic dermatitis.

Authors:
Neha Puar Raj Chovatiya Amy S Paller

Ann Allergy Asthma Immunol 2021 01 17;126(1):21-31. Epub 2020 Aug 17.

Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address:

Objective: To discuss the efficacy and safety of novel and emerging topical and systemic therapeutic agents for atopic dermatitis (AD).

Data Sources: The review of the published literature was performed using the PubMed database, published abstracts and virtual presentations from scientific meetings, posted results on ClinicalTrials.gov, and data from industry press releases. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Efficacy of biologics in atopic dermatitis.

Authors:
Jianni Wu Emma Guttman-Yassky

Expert Opin Biol Ther 2020 05 3;20(5):525-538. Epub 2020 Feb 3.

Department of Dermatology, Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, USA.

: Atopic dermatitis (AD) is a heterogeneous disease. Recent advancements in understanding AD pathogenesis resulted in the exponential expansion of its therapeutic pipeline, particularly following the success and FDA-approval of dupilumab. Different phenotypes of AD by age and ethnicity have also recently been described and clinical studies of emerging treatments will further clarify the role of each cytokine pathway in AD. Read More

View Article and Full-Text PDF
May 2020
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap